最近GDM的女性感知压力和产后早期抑郁症状:对产后生活方式计划的影响
Jennifer M Dias1, Estelle C Kelty2, Jacinda M Nicklas3
1Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Maternal and child health journal
|February 7, 2025
概括
感知到的压力显著预测了孕期糖尿病 (GDM) 的女性产后抑郁症状. 应对压力是旨在预防2型糖尿病的生活方式计划的关键.
科学领域:
- 生殖健康 生殖健康
- 心理健康 心理健康
- 内分泌学 在内分泌学.
背景情况:
- 妊娠期糖尿病 (GDM) 增加了2型糖尿病和产后抑郁症的风险.
- 早期识别产后抑郁症状的危险因素对于干预至关重要.
研究的目的:
- 确定与近期GDM妇女产后抑郁症状相关的因素.
- 为糖尿病预防生活方式计划的制定提供信息.
主要方法:
- 从婴儿干预后平衡 (BABI) 研究中分析数据.
- 使用爱丁堡产后抑郁症量表 (EPDS) 和感知压力量表 (PSS-10) 在产后8周.
- 多变量后勤回归和调解分析,以确定预测因素和调解因素.
主要成果:
- 在181名女性中,有19%的女性经历了抑郁症状 (EPDS ≥9).
- 感知到的压力是产后抑郁症状的重要预测因素 (OR 4.34).
- 感知到的压力完全介导了第一个GDM怀孕对抑郁症状的影响.
结论:
- 感知到的压力是GDM妇女产后抑郁症状的关键因素.
- 在产后早期的生活方式干预中针对感知压力可能会增强糖尿病预防.
- 生活方式计划应纳入压力管理的妇女有史以来的GDM.
相关概念视频
Pathophysiology of Diabetes
848
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
848
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Psychoneuroimmunology: Diabetes and Cancer
22
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
22
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Introduction to Stress and Lifestyle
69
Stress is a multifaceted response to events perceived as challenging or threatening, highlighting physical, emotional, cognitive, and behavioral reactions. Physically, stress can lead to fatigue, sleep disruptions, and various health issues such as frequent colds, chest pains, and nausea. Emotionally, it can manifest as anxiety, depression, irritability, and anger triggered by both minor and major life events. Cognitively, it may result in difficulty in concentration, memory, and...
69
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149


